Your Speaker: Trinity Professor Gerard Beaudoin III '99, Ph.D.
To combat the global coronavirus pandemic, biotechnology companies have mobilized vaccine efforts at an unprecedented breakneck speed. Building on decades of incremental technological breakthroughs, science is poised like never before to address a health emergency. As human trials are underway, at the time of this lecture, we are hopefully only a couple of months out from worldwide administration of a vaccine. Part of the reason for multiple vaccine efforts is that different companies are using novel strategies for vaccine development. This lecture will cover breakthroughs and setbacks of the science and technologies that have led to this moment. You will leave with a more complete grasp of the way biomedical science is being done, and how these strategies are being used to address illnesses in addition to SARS-COV-2.
Wednesday, November 11 at 5:30pmVirtual Event
Login to interact with events, personalize your calendar, and get recommendations.